Greenberg Traurig is a sponsor of the 4th Emerging Frontiers In Oncology Summit on June 30. The summit will focus on new modalities beyond cell therapy for oncology and the drivers of future breakthroughs in oncology across research, innovation, and people. The summit will also facilitate a broad discussion on the future of in situ new modalities in oncology. Greenberg Traurig Shareholder Prashant Girinath, Ph.D. will moderate the innovation debate-style panel "Spectrum of New Modalities."
You May Also Be Interested In: